© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
October 26, 2016
For many patients with early-stage breast cancer, these drugs provide a significant boost to disease-free survival.
Laura Yeager talks about her journey with breast cancer, from the fearful thoughts to the free food at chemotherapy.
Biosimilars are changing the field — and the price — of cancer treatment, though some questions still remain.
October 25, 2016
Extending hormonal therapy to 10 years has been found to reduce recurrence in HR-positive breast cancer.
In some cases, genomic blood analysis may be effective enough to replace cancer biopsies.
Biosimilars are likely to rival name-brand treatments for breast and other cancers, and the competition could drive prices down.
October 23, 2016
Joining cancer registries can help patients and the larger oncology community.
October 22, 2016
Herceptin has improved survival for women with HER2-positive breast cancer. Now, scientists are exploring ways to mitigate the heart problems the drug can cause.
October 21, 2016
Excitement is growing over new strategies for treating or avoiding peripheral neuropathy in patients with cancer.
October 20, 2016
Once considered “immunologically silent,” breast cancer may actually respond to immunotherapy.
From the Chairman
Mothering a Daughter with Cancer
Our Microbiome: A Reflection of Ourselves?
How Can Cancer Survivors Help The Newly Diagnosed?
CURE Honors World Ovarian Cancer Day